000 01547 a2200421 4500
005 20250517045751.0
264 0 _c20161228
008 201612s 0 0 eng d
022 _a1873-5576
024 7 _a10.2174/1568009615666150817120931
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPapi, Alessio
245 0 0 _aEpigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines.
_h[electronic resource]
260 _bCurrent cancer drug targets
_c2016
300 _a373-85 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCatechin
_xanalogs & derivatives
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Synergism
650 0 4 _aForkhead Box Protein O3
_xmetabolism
650 0 4 _aGastrointestinal Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMetalloproteases
_xmetabolism
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aPhenanthrenes
_xpharmacology
650 0 4 _aRetinoid X Receptor gamma
_xmetabolism
650 0 4 _aTea
_xmetabolism
650 0 4 _aTretinoin
_xmetabolism
700 1 _aGovoni, Marzia
700 1 _aCiavarella, Carmen
700 1 _aSpisni, Enzo
700 1 _aOrlandi, Marina
700 1 _aFarabegoli, Fulvia
773 0 _tCurrent cancer drug targets
_gvol. 16
_gno. 4
_gp. 373-85
856 4 0 _uhttps://doi.org/10.2174/1568009615666150817120931
_zAvailable from publisher's website
999 _c25174435
_d25174435